Zhejiang Tianyu Pharmaceutical (300702.SZ)Pregabalin Capsules Obtained Drug Registration Certificate
Tianyu Group (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode...
Zhejiang Tianyu Pharmaceutical (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode Pharmaceutical") recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Prugabalin Capsules.
The announcement stated that Prugabalin Capsules are used to treat postherpetic neuralgia and fibromyalgia, a medication for postherpetic neuralgia.
Related Articles
Russian court rules that Rio Tinto plc Sponsored ADR (RIO.US) must pay RUSAL (00468) approximately US$1.3 billion in damages; Mongolian OT copper mine interests may face enforcement
UBS Group AG: Maintains "Neutral" rating on Tesla, Inc. (TSLA.US), target price $385. AI narrative dominates the stock's pricing logic.
Memory supply shortage may persist until 2028! UBS Group AG raises Micron's (MU.US) earnings, bullish on HBM boom + incremental buybacks.
Russian court rules that Rio Tinto plc Sponsored ADR (RIO.US) must pay RUSAL (00468) approximately US$1.3 billion in damages; Mongolian OT copper mine interests may face enforcement
UBS Group AG: Maintains "Neutral" rating on Tesla, Inc. (TSLA.US), target price $385. AI narrative dominates the stock's pricing logic.
Memory supply shortage may persist until 2028! UBS Group AG raises Micron's (MU.US) earnings, bullish on HBM boom + incremental buybacks.
